These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 16675391)
1. New insights into prion structure and toxicity. Harris DA; True HL Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391 [TBL] [Abstract][Full Text] [Related]
2. The role of rafts in the fibrillization and aggregation of prions. Pinheiro TJ Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049 [TBL] [Abstract][Full Text] [Related]
3. Structuring the puzzle of prion propagation. Eghiaian F Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262 [TBL] [Abstract][Full Text] [Related]
4. PrP interactions with nucleic acids and glycosaminoglycans in function and disease. Silva JL; Gomes MP; Vieira TC; Cordeiro Y Front Biosci (Landmark Ed); 2010 Jan; 15(1):132-50. PubMed ID: 20036811 [TBL] [Abstract][Full Text] [Related]
5. Evolving views in prion glycosylation: functional and pathological implications. Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773 [TBL] [Abstract][Full Text] [Related]
6. Generation of genuine prion infectivity by serial PMCA. Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773 [TBL] [Abstract][Full Text] [Related]
7. A general model of prion strains and their pathogenicity. Collinge J; Clarke AR Science; 2007 Nov; 318(5852):930-6. PubMed ID: 17991853 [TBL] [Abstract][Full Text] [Related]
8. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds. Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787 [TBL] [Abstract][Full Text] [Related]
9. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein. Kellershohn N; Laurent M Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459 [TBL] [Abstract][Full Text] [Related]
10. Prion protein aggregation and fibrillogenesis in vitro. Stöhr J Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001 [TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of prion transmission]. Sakaguchi S Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274 [TBL] [Abstract][Full Text] [Related]
12. The prion's elusive reason for being. Aguzzi A; Baumann F; Bremer J Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863 [TBL] [Abstract][Full Text] [Related]
13. The state of the prion. Weissmann C Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743 [TBL] [Abstract][Full Text] [Related]
14. Prion protein conversion in vitro. Supattapone S J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886 [TBL] [Abstract][Full Text] [Related]
15. Aptamers against prion proteins and prions. Gilch S; Schätzl HM Cell Mol Life Sci; 2009 Aug; 66(15):2445-55. PubMed ID: 19396399 [TBL] [Abstract][Full Text] [Related]